title: Methadone dosage and its relationship to quality of life, satisfaction, psychopathology, cognitive performance and additional consumption of non-prescribed drugs.
abstract: The effectiveness of methadone maintenance treatment is beyond any doubt, but there remains some incertitude about the appropriate and effective dosage and the objectives that should be achieved by this therapy. Some authors maintain that only doses higher than 50-60 mg/day ought to be considered effective, since only these block all the opioid receptors. But others propose the use of doses adjusted to the needs of the patient, based on their recovery process. Quality of life, satisfaction with treatment, psychopathological symptoms, cognitive performance and additional intake of illegal and unprescribed drugs were evaluated in a representative sample of all patients treated with opioid agonists in the Addiction Institute of Madrid (N = 1898, n = 450) and the Junta de Extremadura (N = 100, n = 65). The results revealed a negative relationship between dose and quality of life, psychopathological symptoms and cognitive performance. Satisfaction with treatment, based on doses negotiated together by doctor and patient, was very high, regardless of the dose. To establish hypothetical causal dependencies among the studied variables structural equation modelling was performed. The results reject the need for high dosage if not required by the patient, and highlight the benefits of other psychosocial interventions that lead to recovery, despite the chronification that could imply the use of high doses. Whereas high dosage programmes provide better indicators of social control, the patient's quality of life must be one of the main indicators of a successful treatment, as in any other health problem.
authors.affiliation: Instituto de Adicciones. Madrid Salud. ejpedrero@yahoo.es.
authors.forename: Eduardo J
authors.initials: EJ
authors.lastname: Pedrero-Pérez
authors.forename: Grupo
authors.initials: G
authors.lastname: MethaQoL
mesh_terms: D003071:Cognition / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008691:Methadone / Q000008:administration & dosage* / Q000494:pharmacology; D008875:Middle Aged; D009294:Narcotics / Q000008:administration & dosage* / Q000494:pharmacology; D004366:Nonprescription Drugs / Q000008:administration & dosage*; D058850:Opiate Substitution Treatment; D010549:Personal Satisfaction; D011788:Quality of Life
chemical_list: D009294:Narcotics; D004366:Nonprescription Drugs; D008691:Methadone